SCHEMBL1854355

SCHEMBL1854355

CC(C)(C)N(Cc1nc(C(=O)Nc2c(C(N)=O)oc3ccc(Br)cc23)cs1)C(=O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.43
MAPT P10636 5/20 0.43
HPGD P15428 4/20 0.43
ALDH1A1 P00352 3/20 0.43
KDM4E B2RXH2 5/20 0.42
MEN1 O00255 4/20 0.42
HSD17B10 Q99714 4/20 0.42
TSHR P16473 3/20 0.42
LMNA P02545 2/20 0.37
NPC1 O15118 4/20 0.36
RAB9A P51151 4/20 0.36
POLB P06746 2/20 0.35
NPSR1 Q6W5P4 2/20 0.35
ESR1 P03372 1/20 0.35
APEX1 P27695 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35
TEAD1 P28347 1/20 0.34
YAP1 P46937 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4113977 0.82 ALDH1A1 (0.47) KMT2AMAPTHPGDALDH1A1KDM4E
SCHEMBL4113981 0.81 ALDH1A1 (0.46) KMT2AMAPTHPGDALDH1A1KDM4E
SCHEMBL1854353 0.78 ALDH1A1 (0.43) KMT2AMAPTHPGDALDH1A1KDM4E
SCHEMBL1852416 0.74 HPGD (0.58) KMT2AMAPTHPGDALDH1A1KDM4E
SCHEMBL1853485 0.74 TSHR (0.46) KMT2AMAPTHPGDALDH1A1KDM4E
SCHEMBL1850906 0.72 HPGD (0.58) KMT2AMAPTHPGDALDH1A1KDM4E
SCHEMBL1851522 0.69 MAPT (0.57) KMT2AMAPTHPGDALDH1A1KDM4E
SCHEMBL1858218 0.69 TEAD1 (0.68) KMT2AMAPTHPGDALDH1A1KDM4E
SCHEMBL20679753 0.69 MMP13 (0.43) KMT2AMAPTALDH1A1MEN1LMNA
SCHEMBL1848271 0.68 CSNK2B (0.49)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2097419-B1 BENZOFUROPYRIMIDINONES AS PROTEIN KINASE INHIBITORS EXELIXIS INC (US) 2011-05-25 EP disclosed